GantenerumabAgricultural BiotechnologyUpdated on Feb 10, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant monoclonal antibody to Abeta. Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease. A phase I clinical trial has been conducted in 2006/07. Gantenerumab is currently being evaluated in a prodromal Alzheimer's Disease population in the Scarlet Road study, a global phase II study of approximately 360 subjects in 100 centers in 15 countries.